Izloženost osoblja nuklearne medicine ionizirajućem zračenju u 18F-FDG PET/CT dijagnostici – preliminarna retrospektivna studija by Pavičar, Bojan et al.
216
Original article DOI: 10.2478/aiht-2021-72-3517
 
Nuclear medicine staff exposure to ionising radiation in 
18F-FDG PET/CT practice: a preliminary retrospective 
study
Bojan Pavičar1,4, Jasna Davidović2,6, Biljana Petrović3, Goran Vuleta2, Saša Trivić2,  
Vlatko Šajinović2, Nataša Egeljić-Mihailović2, Nataša Todorović4, and Branko Predojević5
1 Center for Radiation Therapy, International Medical Centers, Affidea, Banja Luka, Bosnia and Herzegovina 
2 University Clinical Centre of the Republic of Srpska, Department of Nuclear Medicine and Thyroid Disorders, Banja 
Luka, Bosnia and Herzegovina 
3 Public Health Institute of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina 
4 University of Novi Sad Faculty of Sciences, Novi Sad, Serbia 
5 University of Banja Luka Faculty of Natural Sciences, Banja Luka, Bosnia and Herzegovina 
6 University of Belgrade School of Electrical Engineering, Belgrade, Serbia
[Received in December 2020; Similarity Check in December 2020; Accepted in September 2021]
This retrospective study provides an insight into the levels of radiation exposure of six nuclear medicine (NM) staff (four 
technologists and two nurses) performing routine diagnostic 18F-fluorodeoxyglucose (18F-FDG) positron emission 
tomography-computed tomography (PET/CT) at the University Clinical Centre of the Republic of Srpska, Department 
of Nuclear Medicine and Thyroid Disorders, Banja Luka, Bosnia and Herzegovina. Data analysis included monthly staff 
exposure measured with personal thermoluminescent dosimeters (TLD) between June and December 2018, quantified in 
terms of normalised dose for the whole body [Hp(10)] and dominant hand [Hp(0.07)] and their comparison between each 
staff member and between the two groups (technologists and nurses). The study goal was to establish how our Department 
compared with reports from other PET/CT centres worldwide in terms of annual number of procedures and exposure 
limits and whether there could be room for further improvements in radiation protection. The number of procedures rose 
considerably from 208 in 2016 to 876 in 2019 and was 423 in the observed seven-month period. Mean individual whole-
body exposure dose per GBq of injected 18F-FDG activity, [Hp(10)/A] was 18.55 µSv/GBq for the four technologists and 
15.61 µSv/GBq for the two nurses. Mean dominant-hand exposure dose per GBq of injected 18F-FDG activity [Hp(0.07)/A] 
was 16.99 µSv/GBq and 25.44 µSv/GBq for the two groups, respectively. The average annual cumulative dose for all 
staff was (1.06±0.29) mSv for Hp(10) and (1.15±0.32) mSv for Hp(0.07). These results are comparable with those of 
similar studies. Staff doses were well below the annual limits. Nurses received slightly higher extremity doses than 
technologists. In view of the increasing trends in the number of PET/CT procedures, dose monitoring should be continued 
to identify exposure hotspots and maintain doses as low as possible.
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Positron emission tomography with computed 
tomography (PET/CT) is a non-invasive, nuclear medicine 
imaging technique that provides valuable diagnostic 
information on the function of internal organs, their 
anatomy, and morphological changes. PET uses imaging 
agents, mostly 18F-fluorodeoxyglucose (18F-FDG) to trace 
glucose metabolism (1). Fluorine-18 has a 109-minute 
half-life and a positron emission of 630 keV. Its physical 
characteristics make it suitable for external detection of 
511 keV annihilation photons but not very suitable for use 
by nuclear medicine (NM) staff. PET/CT procedures 
include many tasks contributing significantly to their 
occupational radiation exposure (2). In addition to the 
working procedures already in place, many other factors 
contribute to the occupational dose, such as staff experience 
and training, workload, the health status of a patient, type 
of PET/CT scanner, administered activity, and CT protocols. 
All this requires continuous efforts by all staff to implement 
correctly the ALARA principle and the International 
Commission on Radiological Protection (ICRP) 
recommendations (3).
Annual dose limits for the whole body [effective dose, 
Hp(10)] and extremities [equivalent dose; Hp(0.07)] are 
20 mSv and 500 mSv, respectively (4). So far, clinical 
experience worldwide has demonstrated that these levels 
are unlikely to be exceeded in the clinical settings based on 
automated dispensing systems, given the observed trends 
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in NM staff doses over the years (5–7). On the other hand, 
Hp(0.07) doses to operating staff working in facilities using 
semi-automated or manual dispensing systems may be 
significantly higher and even surpass the annual limits (4, 
5, 8, 9).
Increasing trends in the number of PET/CT examinations 
and plans to introduce some novel radiopharmaceuticals 
for an ever wider spectrum of clinical indications raise 
concern over increased staff radiation exposure in the 
imminent future. Therefore, it is essential to analyse and 
estimate their risk of exposure in the years to come, taking 
into account current data on the number and type of PET/
CT procedures used, the number of employees involved, 
workload allocation among staff members, and radiation 
protection measures implemented.
The primary aim of our study was to get an insight into 
radiation exposure of PET/CT staff using an automated 
system at the Department of Nuclear Medicine and Thyroid 
Disorders of the University Clinical Centre of the Republic 
of Srpska, Bosnia and Herzegovina, in terms of Hp(10) and 
Hp(0.07). In addition, we wanted to see whether these doses 
comply with the European Association of Nuclear Medicine 
(EANM) guidelines (10) and dose limit regulations (4, 11) 
and how they compare with reports from similar PET/CT 
facilities worldwide in order to see if and which 
improvements in radiation protection are needed.
PARTICIPANTS AND METHODS
This retrospective study analysed staff irradiation from 
June to December 2018 recorded on thermoluminescent 
dosimeters (TLDs) resulting from exposure during routine 
diagnostic procedures with a Discovery 610 PET/CT 
scanner (General Electric, Chicago, IL, USA) and 
MEDRAD? Intego PET Infusion System for automatic 
dispensing and injection of radiopharmaceuticals (Bayer 
HealthCare LLC, Whippany, NJ, USA). MEDRAD® Intego 
can deliver 18F-FDG within ±10 % of the prescribed dose 
and within ±2 % of the measured dose (12). The only 
radiopharmaceutical in use during the observed period was 
18F-FDG. It was delivered to the NM Department in a 
transport container in the form of single doses of fixed 
activity (3.70 GBq or, less frequently, 5.55 GBq each).
We followed six staff members, four of whom were 
certified radiological technologists (T1, T2, T3, T4) and 
two certified nurses (N1, N2). Typically, they were 
organised in shifts of two technologists and one nurse.
The age of the technologists was 38 (T1), 42 (T2), 37 
(T3), and 31 years (T4) and of the nurses 37 (N1) and 42 
years (N2). These six staff members were also occasionally 
involved in other nuclear medicine practices. However, 
from June to December 2018, they worked only on PET/
CT and performed 423 procedures (1–3 per week) in 
patients with an average weight of 80 kg (range 31–160 kg) 
and age 60 years (range 6–86 years). The number of 
procedures performed differed between staff members: T1 
(142), T2 (53), T3 (102), T4 (126), N1 (189), and N2 (234).
Dosimetry
The NM staff was equipped with two passive TLDs 
each, one for the whole body and one for the hands (ring 
dosimeter). The whole-body TLD is worn on the chest, 
whereas the ring dosimeter is worn on the base of the index 
finger of the operator’s dominant hand (Figure 1).
Both whole-body and ring TLD readouts corresponded 
to one month of cumulative dose measurements, as 
stipulated by country regulation (11). TLDs are read by the 
Personal Dosimetry Laboratory at the Public Health 
Institute of the Republic of Srpska. The Laboratory holds 
an accreditation according to ISO/IEC I17025 standard for 
measurements. The TLDs used in this study are of the 
MTS-N (LiF, Ti) type and are read by a semi-automatic 
RADOS RE-200 TLD reader. The detection limit for this 
TLD type is 26 µSv for one-month measurements, and 
measurement uncertainties for the whole body and ring 
TLDs are 28 % and 33 %, respectively (4).
Personal dosimeters are routinely calibrated for Hp(10) 
and Hp(0.07) at the Secondary Standard Dosimetry 
Laboratory (SSDL) of Vinča Institute of Nuclear Sciences, 
Belgrade, Serbia, which has metrological traceability to the 
primary standard at the International Bureau of Weights 
and Measures (BIPM) through the International Atomic 
Energy Agency (IAEA) Dosimetry Laboratory. Furthermore, 
SSDL is accredited to the ISO/IEC 17025 standard.
Data analysis
We analysed normalised whole-body and dominant-
hand exposure doses per GBq of injected 18F-FDG activity 
[Hp(10)/A and Hp(0.07)/A, respectively] per month, 
cumulative Hp(10) and Hp(0.07) doses (µSv), total 
administered activities for each team member, cumulative 
doses Hp(10) and Hp(0.07) per procedure, and total 
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Figure 1 Correct placement for the whole-body and a ring dosimeter
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normalised Hp(10)/A and Hp(0.07)/A for technologists and 
nurses over the seven months.
In order to determine the strength and direction of linear 
correlation, we calculated Pearson’s correlation coefficient 
between Hp(10)/A and Hp(0.07)/A for technologists, 
Hp(10)/A and Hp(0.07)/A for nurses, and Hp(10)/A 
Hp(0.07)/A for all. Strong correlation (r) was considered 
the one between 0.5 and 1, and weak correlation between 
0.1 and 0.29 (13). Mean values of the above pairs of 
normalised doses were compared using the independent 
sample t-test. Data were analysed with software packages 
OriginPro 9.0 (OriginLab Corporation, Northampton, MA, 
USA) and SPSS Statistics 23.0 (IBM, Armonk, NY, USA).
RADIATION PROTECTION MEASURES 
AND WORKFLOW
NM department had in place all appropriate radiation 
protection procedures for PET/CT imaging. Lead-shielded 
transportation containers were used for the transport of the 
radiopharmaceutical according to international standards 
and national legislation on ionising radiation protection, 
which included 10 cm thick lead bricks (occasionally used 
as an additional tool to shield the radiopharmaceutical 
during its transport from the manufacturing facility to the 
NM Department). The NM staff also used 30 cm long 
grasping forceps for safer radiopharmaceutical manipulation 
and the MEDRAD® Intego PET infusion system with the 
following radiation shielding profile: dose rates of 
0.26 mSv/h up to 2.3 mSv/h for the vial shield, peak rate 
≤0.014 mSv/h at 30.5 cm distance from any surface of the 
cart with 27.75 GBq in the vial, and peak rate <0.001 mSv/h 
at 30.5 cm distance from the surface in the operator position 
with 27.75 GBq in the vial (12). The injector itself is 
equipped with tungsten and lead shielding.
Personal protective garments such as lead aprons, 
gloves, and thyroid shields were also available, but not 
routinely used when handling 18F-FDG, as they have been 
found no to provide significant protection (14). Nonetheless, 
individual preferences whether to use them or not were 
always respected. Wearing protective garments may help 
to reduce exposure in rare cases of contamination with liquid 
spills. It is also worth mentioning that the whole-body 
dosimeter, worn at the chest level, may have occasionally 
been covered by the lead apron.
Latex gloves were routinely used for all types of 
operations. They do not protect against beta or gamma 
radiation but provide a physical barrier between the 
radiopharmaceutical and operator’s skin in case of a spill.
Shielding barriers also included walls, doors, and lead 
glazing of the PET/CT scanning and adjacent rooms. PET/
CT scans were performed from the control room shielded 
to block all X-ray and most of gamma radiation. This means 
that the positron-emitting radionuclide was the major 
contributor to the radiation dose to which the technologists 
and nurses were exposed.
In addition to these protective measures, the PET/CT 
facility was designed to ensure a smooth workflow (see 
subsection below) to avoid loss of radionuclide activity due 
to lag times and to minimise time spent in proximity of an 
injected patient. The negative pressure ventilation system 
was independent of the rest of the hospital to limit the 
circulation of radioactive particles (gasses and aerosols) 
and expel radioactive particles. The personnel had also 
received manufacturer-specific, hands-on training to work 
with the GE Discovery 610 PET/CT unit and the MEDRAD® 
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Figure 2 PET/CT facility floor plan design. 1– waiting room 1: 2 – patient prep room; 3 – 18F-FDG injection room; 4 – patient bathroom; 
5 – patient uptake rooms; 6 – waiting room 2; 7 – PET/CT scanning room; 8 – PET/CT control room; 9 – hot laboratory
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Intego PET infusion system ever since the PET/CT system 
was installed in March 2016.
Workflow
Figure 2 shows the floor plan design of the PET/CT 
facility. The technologists and nurses had separate 
responsibilities for the entire duration of patient scanning. 
Other professionals involved in PET/CT procedures (such 
as NM physicians) did not routinely perform any of the 
activities that might have resulted in measurable exposure 
to ionising radiation from radiopharmaceuticals used in 
PET/CT procedures. The workflow could roughly be 
divided into two phases: the first carried out by a nurse and 
the second by a technologist.
In phase 1, the nurse receives the container with 
18F-FDG and places it into the automatic dispensing system. 
The system then calculates 18F-FDG activity to be dispensed 
and injected according to the EANM guidelines (10). Before 
18F-FDG injection, all the scheduled patients are identified 
and registered. The nurse takes the patient from waiting 
room 1 to the patient prep room, where the patient’s blood 
glucose levels are measured and an intravenous cannula 
placed. If blood glucose levels do not fall within the 
reference interval even after a second measurement, the 
procedure is postponed to another day. Otherwise, the nurse 
takes the patient to the 18F-FDG injection room. The 
automated injection process takes about 30 seconds, and 
during that time, the nurse waits outside the injection room 
to avoid exposure. After injection, the patient is instructed 
to rest on the bed in one of the two patient uptake rooms 
for 60 minutes, covered with a quilt or two blankets.
In phase 2, at the end of the uptake time, the technologist 
sitting in the PET/CT control room instructs the patient via 
speakerphone to go to the patient bathroom to empty her/
his bladder, and escorts her/him to the scanning room, 
positions the patient on the scanner bench, and makes the 
scan. Scanning takes between 20 and 45 minutes, depending 
on the size of the region scanned and the protocol used 
(usually ‘whole body’ or ‘total body’). Whenever the total 
body scanning protocol is performed, the technologist must 
re-enter the scanning room and reposition the patient, which 
results in increased exposure. Then the technologist escorts 
the patient to waiting room 2, where the patient waits for 
the physician and/or radiologist to review the obtained PET/
CT images. If the images are good, the patient is released 
from the Department. Otherwise, the patient is immediately 
asked to do another round of imaging. The same procedure 
is repeated until all the scheduled patients are processed.
RESULTS AND DISCUSSION
From 2016 to 2019, the annual number of PET/CT 
procedures at the NM Department increased from 208 to 
Table 1 Period under consideration, number of PET/CT workdays, number of PET/CT procedures and total injected activity
Observed period 
(month) in 2018
Number of PET/CT 
workdays
Number of PET/CT 
procedures
Total injected 18F-FDG activity 
(GBq)
June 6 44 11.7
July 7 53 14.2
August 8 62 15.7
September 7 47 12.3
October 10 76 19.5
November 11 85 21.3
December 8 56 14.3
Total: 57 423 109.0
Figure 3 Normalised whole-body exposure dose per GBq of injected 18F-FDG activity per month for technologists
220
876, which clearly confirms an increasing trend in PET/CT 
scans observed worldwide (5).
From the total number of procedures and injected 
activities over the seven months of our study (Table 1) we 
calculated the average activity of 258 MBq per procedure, 
which is slightly lower than activities per procedure reported 
in Lithuania (283 MBq) (7), Oman (298 MBq) (8), or India 
(308 MBq) (15) and mainly reflects differences in 
parameters between patients (15), use of different guidelines 
for radiopharmaceutical injection in terms of patient age 
and weight, and the uncertainties in injection dose 
measurements.
Figures 3 and 4 show normalised monthly whole-body 
and dominant-hand exposure doses for technologists. We 
can see that normalised doses are not uniformly distributed 
across the months and individual technologists, as they 
depended on the distribution of working days and workload 
of each technologist. Normalised monthly whole-body and 
dominant-hand exposure doses for nurses are shown in 
Figures 5 and 6.
Cumulative normalised doses for whole-body and 
dominant-hand exposure for the same period are shown in 
Figures 7a and b for the technologists and 8a and 8b for the 
nurses. These figures show that the nurses’ hands were more 
exposed to radiation than those of the technologists.
Table 2 compares the monthly normalised exposure 
doses for technologists and nurses. We found a strong 
correlation between normalised exposure doses Hp(10)/A 
and Hp(0.07)/A for technologists (r=0.61), Hp(10)/A and 
Hp(0.07)/A for nurses (r=0.85), and between Hp(10)/A for 
technologists and nurses (r=0.65). These results reveal that 
the compared pairs of normalised doses changed similarly 
over time. In contrast, the correlation between Hp(0.07)/A 
for technologists and nurses was weak (r=0.25). No 
significant differences between mean normalised doses were 
found.
Table 3 presents the Hp(10) and Hp(0.07) cumulative 
doses and activities per staff member for the observed seven 
months. Average cumulative Hp(10) and Hp(0.07) doses 
(with standard error of the mean, SEM) were (505±171) µSv 
and (462±91) µSv for the technologists and (850±258) µSv 
and (1385±353) µSv for the nurses, respectively. The 
average cumulative Hp(10) and Hp(0.07) doses for all staff 
members were (0.62±0.17) mSv and (0.76±0.21) mSv, 
respectively. As the cumulative dose is a linear function of 
time (5, 16), we extrapolated the average annual cumulative 
dose for the PET/CT staff to be (1.06±0.29) mSv for Hp(10) 
and (1.15±0.32) mSv for Hp(0.07), which is significantly 
lower than the respective limits of 20 mSv (or the dose 
constraint of 2 mSv) and 500 mSv (11).
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Table 2 Normalised monthly doses per unit of injected activity
Hp(10)/A (µSv/GBq) Hp(0.07)/A (µSv/GBq)
Technologists Nurses Technologists Nurses
June 9.2±2.7 18±6 9±3 40±14
July 42±13 23±8 40±12 30±10
August 19±6 9±3 3.2±1.0 13±4
September 20±6 18±6 35.±10 31±10
October 24±7.1 20±7 10±3 30±10
November 5.3±1.6 9±3 16±5 12±4
December 19±6 20±7 16±5 36±13
Hp(10)/A – normalised whole-body dose per GBq of injected 18F-FDG activity. Hp(0.07)/A – normalised dominant-hand dose per GBq 
of injected 18F-FDG activity
Figure 4 Normalised dominant-hand exposure dose per GBq of injected 18F-FDG activity per month for technologists
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Technologist 1 0.76±0.21 0.50±0.14 31±3
Technologist 2 0.08±0.02 0.27±0.08 14.2±1.4
Technologist 3 0.37±0.10 0.38±0.11 25.9±2.6
Technologist 4 0.81±0.23 0.70±0.20 38±4
Nurse 1 0.59±0.19 1.0±0.3 51±5
Nurse 2 1.1±0.4 1.7±0.6 58±6
Hp(10) – whole-body received dose. Hp(0.07) – dominant-hand received dose
Table 4 Comparison between ours and other studies available in the literature (maximum values shown in parentheses)














Technologist 4.78 (15.64) 18.55 4.37 (15.38) 16.99
Yes
Nurse 4.02 (8.83) 15.61 6.55 (28.17) 25.44
Study 1 (ref. 5) Technologist 4.2–7.0 17–19 - - Yes
Study 2 (ref. 6) Technologist 2.5±2.1 - - - Yes
Study 3 (ref. 7) Technologist 1.72±0.33/ 1.16±0.11 - - - Yes
Study 4 (ref. 8) Technologist 4.17 - - - Yes
Study 5 (ref. 15) Physicians 2.1 6.8 - - No
Technologist 0.6 1.9
Study 6 (ref. 17)
Technologist 4.77±0.52 10.3±1.1 - -
NoNurse 5.79±0.59 12.5±1.2 - -
Med. physicist 5.07±0.51 10.9±1.1 - -
Study 7 (Ref. 18)
Technologist - - 38.77±7.33 -
NoNurse - - 59.6±6.33 -
Med. physicist - - 203.5±17.74 -
Hp(10)/A– normalised whole-body dose per GBq of injected 18F-FDG activity; Hp(0.07)/A – normalised dominant-hand dose per GBq 
of injected 18F-FDG activity. Hp(10) – whole-body dose; Hp(0.07) – dominant-hand dose
Figure 5 Normalised whole-body exposure dose per GBq of injected 18F-FDG activity per month for nurses
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Table 4 provides a comparative analysis of our data to 
those published in the literature. Hp(10)/procedure and 
Hp(10)/A of injected 18F-FDG established in our study are 
in good agreement with several other reports (5, 6, 8, 17) 
but not with some other studies (7, 15), probably due to 
different workflow between the compared centres. 
Hp(0.07)/procedure in our study was compared with only 
one study (18), and a weak agreement was found. In our 
opinion, this is mainly due to the different processes of 
dispersion and injection of the radiopharmaceutical. To our 
knowledge, there are no other data for Hp(0.07)/A of 
injected 18F-FDG in the literature that could be compared 
to our values.
CONCLUSION
Our study has several limitations. First, the dosimeters 
are supposed to be read in regular intervals (once a month), 
but retrospectively we found that readout times sometimes 
were longer than a month. Another issue with retrospective 
studies of this kind is that one cannot check whether 
dosimeters were worn correctly or whether additional 
exposure occurred from accidental 18F-FDG extravasation 
in patients with obstructed veins.
The doses received by our staff were well below the 
legal limits and are in good agreement with the doses 
reported in other available studies. Regardless of this, it is 
necessary to further optimise the procedure following the 
ALARA principle and to investigate in more detail the 
ergonomics and exposure potential of each step.
Future studies in this field should address staff eye doses 
for PET/CT procedures, as almost all studies made so far 
lack these data.
The limitations of this retrospective study also provide 
a helpful indication how to improve further research by 
Figure 6 Normalised dominant-hand exposure dose per GBq of injected 18F-FDG activity per month for nurses
Figure 7 Normalised cumulative a) whole-body and b) dominant-hand dose over the seven months of the study for technologists
Figure 8 Normalised cumulative a) whole-body and b) dominant-hand dose over the seven months of the study for nurses
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prospectively monitoring staff at risk of exposure with 
real-time dosimeters in combination with TLDs and by 
tracking exposure from various radiopharmaceuticals.
REFERENCES
1. Wernick MN, Aarsvold JN. Emission Tomography: The 
Fundamentals of PET and SPECT. Cambridge (MA): Elsevier 
Academic Press; 2004.
2. Alenezi A, Soliman K. Trends in radiation protection of 
positron emission tomography/computed tomography 
imaging. Annals of the ICRP 2015;44(Suppl 1):259–75. doi: 
10.1177/0146645314551671
3. IAEA Safety Standards. Radiation Protection and Safety of 
Radiation Sources: International Basic Safety Standards. 
IAEA Safety Standards Series No. GSR Part 3, 2014 
[displayed 25 August 2021]. Available at https://www-pub.
iaea.org/MTCD/publications/PDF/Pub1578_web-57265295.
pdf
4. The 2007 Recommendations of the International Commission 
on Radiological Protection. ICRP publication 103. Ann ICRP 
2007;37(2–4):1–332. doi: 10.1016/j.icrp.2007.10.003
5. Antic V, Ciraj-Bjelac O, Stankovic J, Arandjic D, Todorovic 
N, Lucic S. Radiation exposure to nuclear medicine staff 
involved in PET/CT practice in Serbia. Radiat Prot Dosimetry 
2014;162:577–85. doi: 10.1093/rpd/ncu001
6. Tomše P, Biček A. Radiation exposure in routine practice 
with PET/CT and automatic infusion system - Practical 
experience report. In: Bamidis PD, Pallikarakis N, editors. 
IFMBE Proceedings of XII Mediterranean Conference on 
Medical and Biological Engineering and Computing 2010; 
Vol 29. 27–30 May 2010. Chalkidiki, Greece 2010. p. 
719–21.
7. Skovorodko K, Bareikė M, Gudelis A, Gricienė B. 
Occupational exposure in a PET/CT facility using two 
different automatic infusion systems. Phys Med 2020;7:169–
75. doi: 10.1016/j.ejmp.2020.08.014
8. Al-Aamria M, Al-Balushia N, Bailey D. Estimation of 
radiation exposure to workers during [18F] FDG PET/CT 
procedures at Molecular Imaging Center, Oman. J Med 
Imaging Radiat Sci 2019;50:565–70. doi: 10.1016/j.
jmir.2019.05.009
9. Li W, Fang L, Li J. Exposure doses to technologists working 
i n  7  P E T / C T  d e p a r t m e n t s .  D o s e  R e s p o n s e 
2 0 2 0 ; 1 8 ( 3 ) : 1 5 5 9 3 2 5 8 2 0 9 3 8 2 8 8 .  d o i : 
10.1177/1559325820938288
10. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, 
Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike 
LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, 
Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra 
J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, 
Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ, 
European Association of Nuclear Medicine (EANM). FDG 
PET/CT: EANM procedure guidelines for tumour imaging: 
version 2.0. Eur J Nucl Med Mol Imaging 2015;42:328–54. 
doi: 10.1007/s00259-014-2961-x
11. Regulation on Radiation Protection for Occupational and 
Public Exposure. Official Gazette B&H No 102/11 [displayed 
25 August 2021]. Available at http://www.darns.gov.ba/en/
EnglishDARNS/RegulationsDescription
12. MEDRAD, INC. MEDRADTM IntegoTM Infusion System. 
Operation Manual, 2008–2013 [displayed 25 August 2021]. 
Available at http://omr.imaxeon.com.au/omr/online/
Download/OM_INTEGO_2_3031103.pdf
13. Cohen JW. Statistical Power Analysis for the Behavioral 
Sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum 
Associates; 1988.
14. Fonseca RB, Amaral A. Effectiveness of lead aprons in 
positron emission tomography. In: IRPA 12: 12th International 
congress of the International Radiation Protection Association 
(IRPA): Strengthening radiation protection worldwide; 
Buenos Aires, Argentina, 2008 [displayed 25 August 2021]. 
Av a i l a b l e  a t  h t t p s : / / i n i s . i a e a . o rg / c o l l e c t i o n /
NCLCol lec t ionStore /_Publ ic /41/003/41003294.
pdf?r=1&r=1
15. Kumar S, Pandey AK, Sharma P, Shamim SA, Malhotra A, 
Kumar R. Instantaneous exposure to nuclear medicine staff 
involved in PET-CT imaging in developing countries: 
experience from a tertiary care centre in India. Jpn J Radiol 
2012;30:291–5. doi: 10.1007/s11604-011-0045-4
16. Costa PF, Reinhardt M, Poppe B. Occupational exposure 
from F-18-FDG PET/CT: implementation to routine clinical 
practice. Radiat Prot Dosim 2018;179:291–8. doi: 10.1093/
rpd/ncx276
17. Emad El-din MM, Mahmoud RMM, Abaza A, Ez El-din MR, 
Eid I, Rizk RA. Occupational radiation exposure in PET/CT 
units. Arab J Nucl Sci Appl 2017;50:58–65.
18. Saad I, Yassin H. Finger radiation doses received by different 
nuclear medicine working professions in three PET/ CT 
centers. Egyptian J Nucl Med 2018;17:63–77. doi: 10.21608/
egyjnm.2018.46235
Pavičar B, et al. Nuclear medicine staff exposure to ionising radiation in 18F-FDG PET/CT practice: a preliminary retrospective study 
Arh Hig Rada Toksikol 2021;72:216-224
224 Pavičar B, et al. Nuclear medicine staff exposure to ionising radiation in 18F-FDG PET/CT practice: a preliminary retrospective study Arh Hig Rada Toksikol 2021;72:216-224
Izloženost osoblja nuklearne medicine ionizirajućem zračenju u 18F-FDG PET/CT dijagnostici – preliminarna 
retrospektivna studija
Ova retrospektivna studija pruža uvid u razinu izloženosti ionizirajućem zračenju za šestero zaposlenih (četiri radiološka 
tehničara i dvije medicinske sestre) koji izvode rutinska dijagnostička ispitivanja primjenom 18F-FDG na PET/CT-u u 
Kliničkom zavodu za nuklearnu medicinu i bolesti štitne žlijezde Univerzitetskoga kliničkog centra Republike Srpske 
(Banja Luka, Bosna i Hercegovina). Analiza podataka obuhvatila je mjesečnu izloženost osoblja, koja je od lipnja do 
prosinca 2018. mjerena osobnim termoluminiscentnim dozimetrima (TLD-ima), a izražena je normaliziranom dozom za 
cijelo tijelo [Hp(10)] te dozom za dominantnu ruku [Hp(0,07)]. Također, u obzir je uzeta i usporedba tih veličina između 
svakoga člana osoblja te između dviju skupina (radiološki tehničari i medicinske sestre). Cilj studije bio je usporediti 
izvješća našega Zavoda i drugih PET/CT centara u svijetu u pogledu godišnjega broja postupaka, granica izloženosti 
osoblja te mogućnosti uvođenja dodatnih poboljšanja mjera zaštite od zračenja. Ustanovljeno je da se broj postupaka 
znatno povećao (s 208 u 2016. na 876 u 2019. godini), a tijekom praćenoga sedmomjesečnog razdoblja iznosio je 423. 
Srednja vrijednost pojedinačne doze za cijelo tijelo po jedinici aplicirane aktivnosti 18F-FDG [Hp(10)/A] iznosila je 
18,55 µSv/GBq za četvero radioloških tehničara i 15,61 µSv/GBq za dvije medicinske sestre. Srednja vrijednost doze za 
dominantnu ruku po jedinici aplicirane aktivnosti 18F-FDG [Hp(0,07)/A] iznosila je 16,99 µSv/GBq i 25,44 µSv/GBq za 
te dvije skupine. Srednja vrijednost godišnje kumulativne doze za svih šestero zaposlenih iznosila je (1,06±0,29) mSv za 
Hp(10) i (1,15±0,32) mSv za Hp(0,07). Ovi su rezultati usporedivi s rezultatima sličnih studija. Doze za osoblje bile su 
znatno ispod propisanih godišnjih limita. Medicinske sestre imale su nešto više vrijednosti doza za ekstremitete (ruke) 
nego radiološki tehničari. Imajući u vidu tendenciju povećanja broja PET/CT postupaka, potrebno je nastaviti monitoring 
doza za osoblje kako bi se identificirale faze radnoga procesa koje dovode do najveće izloženosti osoblja, a zatim smanjile 
doze za osoblje.
KLJUČNE RIJEČI: 18F-fluorodeoksiglukoza; ALARA; sustav za automatsko ubrizgavanje radiofarmaka; pozitronska 
emisijska tomografija s kompjutoriziranom tomografijom; profesionalna doza; termoluminiscentni dozimetri; TLD
